54 related articles for article (PubMed ID: 17068304)
1. Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial.
Lees KR; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Ashwood T; Hardemark HG; Wasiewski W; Emeribe U; Zivin JA;
Stroke; 2006 Dec; 37(12):2970-8. PubMed ID: 17068304
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
Houkin K; Osanai T; Uchiyama S; Minematsu K; Taguchi A; Maruichi K; Niiya Y; Asaoka K; Kuga Y; Takizawa K; Haraguchi K; Yoshimura S; Kimura K; Tokunaga K; Aoyama A; Ikawa F; Inenaga C; Abe T; Tominaga A; Takahashi S; Kudo K; Fujimura M; Sugiyama T; Ito M; Kawabori M; Hess DC; Savitz SI; Hirano T;
JAMA Neurol; 2024 Feb; 81(2):154-162. PubMed ID: 38227308
[TBL] [Abstract][Full Text] [Related]
3. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
Stan A; Birle C; Blesneag A; Iancu M
J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
[No Abstract] [Full Text] [Related]
4. A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke.
Laskowitz DT; Troy J; Poehlein E; Bennett ER; Shpall EJ; Wingard JR; Freed B; Belagaje SR; Khanna A; Jones W; Volpi JJ; Marrotte E; Kurtzberg J
Stem Cells Transl Med; 2024 Feb; 13(2):125-136. PubMed ID: 38071749
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of High-Dose and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcomes in Patient with Acute Ischemic Stroke: A Randomized, Double-Blind, Parallel, Controlled Trial.
Uransilp N; Chaiyawatthanananthn P; Muengtaweepongsa S
Neurol Res Int; 2018; 2018():7268924. PubMed ID: 29850244
[TBL] [Abstract][Full Text] [Related]
6. Sex as a biological variable in determining the metabolic changes influencing acute ischemic stroke outcomes-Where is the data: A systematic review.
Dylla L; Higgins HM; Piper C; Poisson SN; Herson PS; Monte AA
Front Neurol; 2022; 13():1026431. PubMed ID: 36504643
[TBL] [Abstract][Full Text] [Related]
7. The Role of Oxidative Stress in Acute Ischemic Stroke-Related Thrombosis.
Li Z; Bi R; Sun S; Chen S; Chen J; Hu B; Jin H
Oxid Med Cell Longev; 2022; 2022():8418820. PubMed ID: 36439687
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective efficacy of N-t-butylhydroxylamine (NtBHA) in transient focal ischemia in rats.
Kim ES; Shin Y; Kim EH; Kim D; De Felice M; Majid A; Bae ON
Toxicol Res; 2022 Oct; 38(4):479-486. PubMed ID: 36277357
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive cytoprotective therapies in acute ischemic stroke: a systematic review.
Mulder IA; van Bavel ET; de Vries HE; Coutinho JM
Fluids Barriers CNS; 2021 Oct; 18(1):46. PubMed ID: 34666786
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke.
Martínez-Alonso E; Escobar-Peso A; Ayuso MI; Gonzalo-Gobernado R; Chioua M; Montoya JJ; Montaner J; Fernández I; Marco-Contelles J; Alcázar A
Antioxidants (Basel); 2020 Mar; 9(4):. PubMed ID: 32244303
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy following ischaemic stroke - Continue or change pre-existing therapy?
Mazlan-Kepli W; MacIsaac RL; Walters M; Bath PM; Dawson J
Eur Stroke J; 2017 Mar; 2(1):31-36. PubMed ID: 31008300
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Base Excision Repair of Mitochondrial DNA to Reduce Ischemic Injury Following Reperfusion.
Simon R; Meller R; Yang T; Pearson A; Wilson G
Transl Stroke Res; 2019 Dec; 10(6):664-671. PubMed ID: 30535792
[TBL] [Abstract][Full Text] [Related]
13. Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors.
Chen R; Lai UH; Zhu L; Singh A; Ahmed M; Forsyth NR
Front Cell Dev Biol; 2018; 6():132. PubMed ID: 30364203
[TBL] [Abstract][Full Text] [Related]
14. Targeting oxidative stress for the treatment of ischemic stroke: Upstream and downstream therapeutic strategies.
Li W; Yang S
Brain Circ; 2016; 2(4):153-163. PubMed ID: 30276293
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Stress and the Use of Antioxidants in Stroke.
Shirley R; Ord EN; Work LM
Antioxidants (Basel); 2014 Jul; 3(3):472-501. PubMed ID: 26785066
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.
Lioutas VA; Alfaro-Martinez F; Bedoya F; Chung CC; Pimentel DA; Novak V
Transl Stroke Res; 2015 Aug; 6(4):264-75. PubMed ID: 26040423
[TBL] [Abstract][Full Text] [Related]
17. Asymmetry of deep medullary veins on susceptibility weighted MRI in patients with acute MCA stroke is associated with poor outcome.
Mucke J; Möhlenbruch M; Kickingereder P; Kieslich PJ; Bäumer P; Gumbinger C; Purrucker J; Mundiyanapurath S; Schlemmer HP; Bendszus M; Radbruch A
PLoS One; 2015; 10(4):e0120801. PubMed ID: 25849958
[TBL] [Abstract][Full Text] [Related]
18. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.
Kawakami M
Brain Sci; 2013 Sep; 3(3):1325-56. PubMed ID: 24961531
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
